Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
minocycline (minocin) (1 trial)
nicotine (nicorette) (1 trial)
vitamin q (1 trial)
Atrophy (Phase 3)
Multiple System Atrophy (Phase 3)
Paralysis (Phase 2)
Parkinson Disease (Phase 2)
Shy-Drager Syndrome (Phase 3)
Supranuclear Palsy, Progressive (Phase 2)
Trials (3 total)
Trial APIs (3 total)